全文获取类型
收费全文 | 16615篇 |
免费 | 920篇 |
国内免费 | 83篇 |
专业分类
耳鼻咽喉 | 248篇 |
儿科学 | 368篇 |
妇产科学 | 319篇 |
基础医学 | 2361篇 |
口腔科学 | 1884篇 |
临床医学 | 1201篇 |
内科学 | 3306篇 |
皮肤病学 | 359篇 |
神经病学 | 1018篇 |
特种医学 | 344篇 |
外科学 | 1763篇 |
综合类 | 91篇 |
一般理论 | 6篇 |
预防医学 | 1930篇 |
眼科学 | 383篇 |
药学 | 1198篇 |
中国医学 | 179篇 |
肿瘤学 | 660篇 |
出版年
2024年 | 22篇 |
2023年 | 163篇 |
2022年 | 384篇 |
2021年 | 690篇 |
2020年 | 437篇 |
2019年 | 584篇 |
2018年 | 683篇 |
2017年 | 474篇 |
2016年 | 556篇 |
2015年 | 601篇 |
2014年 | 809篇 |
2013年 | 929篇 |
2012年 | 1453篇 |
2011年 | 1516篇 |
2010年 | 792篇 |
2009年 | 622篇 |
2008年 | 1018篇 |
2007年 | 968篇 |
2006年 | 801篇 |
2005年 | 692篇 |
2004年 | 657篇 |
2003年 | 526篇 |
2002年 | 451篇 |
2001年 | 252篇 |
2000年 | 230篇 |
1999年 | 199篇 |
1998年 | 94篇 |
1997年 | 52篇 |
1996年 | 46篇 |
1995年 | 36篇 |
1994年 | 31篇 |
1993年 | 24篇 |
1992年 | 69篇 |
1991年 | 69篇 |
1990年 | 62篇 |
1989年 | 61篇 |
1988年 | 63篇 |
1987年 | 72篇 |
1986年 | 55篇 |
1985年 | 47篇 |
1984年 | 29篇 |
1983年 | 32篇 |
1982年 | 23篇 |
1981年 | 18篇 |
1980年 | 14篇 |
1979年 | 17篇 |
1975年 | 17篇 |
1974年 | 17篇 |
1973年 | 20篇 |
1969年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
Jamal A. Ahmed Edna Moturi Paul Spiegel Marian Schilperoord Wagacha Burton Nailah H. Kassim Abdinoor Mohamed Melvin Ochieng Leonard Nderitu Carlos Navarro-Colorado Heather Burke Susan Cookson Thomas Handzel Lilian W. Waiboci Joel M. Montgomery Eyasu Teshale Nina Marano 《Emerging infectious diseases》2013,19(6):1010-1011
152.
Flávia Raquel Santos Lucena Larissa C.C. de Araújo Maria do D. Rodrigues Teresinha G. da Silva Valéria R.A. Pereira Gardênia C.G. Militão Danilo A.F. Fontes Pedro J. Rolim-Neto Fausthon F. da Silva Silene C. Nascimento 《Biomedicine & Pharmacotherapy》2013
This study aimed to evaluate the mechanism associated with cytotoxic activity displayed by the drug 5-fluorouracil incorporated in Cu-BTC MOF and its slow delivery from the Cu-BTC MOF. Structural characterization encompasses elemental analysis (CHNS), differential scanning calorimetry (DSC), thermogravimetric analysis (TG/DTG), Fournier transform infrared (FIT-IR) and X-ray diffraction (XRD) was performed to verify the process of association between the drug 5-FU and Cu-BTC MOF. Flow cytometry was done to indicate that apoptosis is the mechanism responsible for the cell death. The release profile of the drug 5-FU from Cu-BTC MOF for 48 hours was obeisant. Also, the anti-inflammatory activity was evaluated by the peritonitis testing and the production of nitric oxide and pro-inflammatory cytokines were measured. The chemical characterization of the material indicated the presence of drug associated with the coordination network in a proportion of 0.82 g 5-FU per 1.0 g of Cu-BTC MOF. The cytotoxic tests were carried out against four cell lines: NCI-H292, MCF-7, HT29 and HL60. The Cu-BTC MOF associated drug was extremely cytotoxic against the human breast cancer adenocarcinoma (MCF-7) cell line and against human acute promyelocytic leukemia cells (HL60), cancer cells were killed by apoptosis mechanisms. The drug demonstrated a slow release profile where 82% of the drug was released in 48 hours. The results indicated that the drug incorporated in Cu-BTC MOF decreased significantly the number of leukocytes in the peritoneal cavity of rodents as well as reduced levels of cytokines and nitric oxide production. 相似文献
153.
C.A.P.F. Alves U. Lbel J.S. Martin-Saavedra S. Toescu M.H. Tsunemi S.R. Teixeira K. Mankad D. Hargrave T.S. Jacques C. da Costa Leite F.G. Gonalves A. Vossough F. D'Arco 《AJNR. American journal of neuroradiology》2021,42(5):961
BACKGROUND AND PURPOSE:Primary posterior fossa tumors comprise a large group of neoplasias with variable aggressiveness and short and long-term outcomes. This study aimed to validate the clinical usefulness of a radiologic decision flow chart based on previously published neuroradiologic knowledge for the diagnosis of posterior fossa tumors in children.MATERIALS AND METHODS:A retrospective study was conducted (from January 2013 to October 2019) at 2 pediatric referral centers, Children''s Hospital of Philadelphia, United States, and Great Ormond Street Hospital, United Kingdom. Inclusion criteria were younger than 18 years of age and histologically and molecularly confirmed posterior fossa tumors. Subjects with no available preoperative MR imaging and tumors located primarily in the brain stem were excluded. Imaging characteristics of the tumors were evaluated following a predesigned, step-by-step flow chart. Agreement between readers was tested with the Cohen κ, and each diagnosis was analyzed for accuracy.RESULTS:A total of 148 cases were included, with a median age of 3.4 years (interquartile range, 2.1–6.1 years), and a male/female ratio of 1.24. The predesigned flow chart facilitated identification of pilocytic astrocytoma, ependymoma, and medulloblastoma sonic hedgehog tumors with high sensitivity and specificity. On the basis of the results, the flow chart was adjusted so that it would also be able to better discriminate atypical teratoid/rhabdoid tumors and medulloblastoma groups 3 or 4 (sensitivity = 75%–79%; specificity = 92%–99%). Moreover, our adjusted flow chart was useful in ruling out ependymoma, pilocytic astrocytomas, and medulloblastoma sonic hedgehog tumors.CONCLUSIONS:The modified flow chart offers a structured tool to aid in the adjunct diagnosis of pediatric posterior fossa tumors. Our results also establish a useful starting point for prospective clinical studies and for the development of automated algorithms, which may provide precise and adequate diagnostic tools for these tumors in clinical practice.In the past 10 years, there has been an exponential increase in knowledge of the molecular characteristics of pediatric brain tumors, which was only partially incorporated in the 2016 World Health Organization Classification of Tumors of the Central Nervous System.1 The main update in the 2016 Classification was the introduction of the molecular profile of a tumor as an important factor for predicting different biologic behaviors of entities which, on histology, look very similar or even indistinguishable.2 A typical example is the 4 main groups of medulloblastoma: wingless (WNT), sonic hedgehog (SHH) with or without the p53 mutation, group 3, and group 4. Although they may appear similar on microscopy, these categories have distinct molecular profiles, epidemiology, prognosis, and embryologic origin.3Subsequent to the publication of the 2016 World Health Organization Classification, further studies have identified even more molecular subgroups of medulloblastoma with possible prognostic implications4 and also at least 3 new molecular subgroups of atypical teratoid/rhabdoid tumor (AT/RT)5 and several subgroups of ependymoma.6 MR imaging shows promise as a technique for differentiating histologic tumors and their molecular subgroups. This capability relies on not only various imaging characteristics but also the location and spatial extension of the tumor, evident on MR imaging, which can be traced to the embryologic origin of the neoplastic cells.5,7-10One approach to the challenge of identifying imaging characteristics of different tumors in children is to use artificial intelligence. Yet despite this exciting innovation, correctly identifying the location of the mass and its possible use as an element for differential diagnosis still requires the expertise of an experienced radiologist. Previously, D''Arco et al11 proposed a flow chart (Fig 1) for the differential diagnosis of posterior fossa tumors in children based on epidemiologic, imaging signal, and location characteristics of the neoplasm. The aims of the current study were the following: 1) to validate, in a retrospective, large cohort of posterior fossa tumors from 2 separate pediatric tertiary centers, the diagnostic accuracy of that flow chart, which visually represents the neuroadiologist''s mental process in making a diagnosis of posterior fossa tumors in children, 2) to describe particular types of posterior fossa lesions that are not correctly diagnosed by the initial flow chart, and 3) to provide an improved, clinically accessible flow chart based on the results.Open in a separate windowFIG 1.Predesigned radiologic flow chart created according to the literature before diagnostic accuracy analysis. The asterisk indicates brain stem tumors excluded from the analysis. Double asterisks indicate relative to gray matter. Modified with permission from D''Arco et al.11 相似文献
154.
155.
156.
Vicência Mara Rodrigues de Lima Claudia Pinto Marques Souza de Oliveira Letícia Yumi Sawada Hermes Vieira Barbeiro Evandro Sobroza de Mello Francisco Garcia Soriano Venancio Avancini Ferreira Alves Stephen H Caldwell Flair José Carrilho 《Liver international》2007,27(2):227-234
BACKGROUND: Oxidative stress plays a role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Yo jyo hen shi ko (YHK) is a complex compound purported to reduce reactive oxygen species (ROS) by blocking the propagation of radical-induced reactions. The aim of this study was to evaluate the role of the effect of YHK in experimental NASH. METHODS: NASH was induced in male ob/ob mice by a high-fat (HF) diet or methionine/choline-deficient (MCD) diet for 4 weeks. YHK-treated animals received YHK solution orally (20 mg/kg/day) in both experimental diets (n=6; each group) while control animals received only vehicle. RESULTS: The MCD and HF groups developed moderate diffuse macrosteatosis, hepatocellular ballooning, and a diffuse inflammatory infiltrate. With the addition of YHK, there was a marked reduction in macrosteatosis in both groups. This was associated with decreased lipoperoxide and reduced glutathione-GSH concentrations as well as reduced serum aminotransferases and improved histological markers of inflammation. These changes were also associated with weight loss in the MCD+YHK group and diminished weight gain in the HF+YHK group. CONCLUSION: YHK therapy blunts the development of macrosteatosis in these models of NASH and significantly reduces markers of oxidative stress. YHK also diminishes weight gain in this obesity prone model. Our findings warrant further study on the mechanisms involved with these effects. 相似文献
157.
158.
159.
Lazzarini LC de Fatima do Amparo Teixeira M Souza Rodrigues R Marcos Nunes Valiante P 《Respiration; international review of thoracic diseases》2008,76(3):356-360
Necrotizing sarcoid granulomatosis (NSG) is a rare entity mainly characterized by a prominent granulomatous vasculitis affecting middle-aged or old individuals and with a favorable prognosis. Although many believe it is a variant of sarcoidosis, the proper classification is still a matter of debate as some of its features are found in sarcoidosis but also in Churg-Strauss syndrome, Wegener's disease and hypersensitivity pneumonitis. In this paper, we described for the first time a case of NSG in a family with several cases of sarcoidosis, reinforcing the relationship between NSG and sarcoidosis. Additional interesting findings were the young age of the patient (15 years old), the symptoms limited to the respiratory tract (uncommon when NSG affects youngsters) and the increase in serologic markers of autoimmune disease. Though complete criteria for autoimmune disease were not present, systemic lupus erythematosus and Sjogren's syndrome are possible candidates. As sarcoidosis is described to be associated with several autoimmune diseases, this finding is an additional suggestion of the relationship between both entities. 相似文献
160.